AI-generated summary
In this single-arm observational study of 118 patients with head and neck cancer receiving radiotherapy or chemoradiotherapy in Brazil, all received daily prophylactic photobiomodulation. The authors report an oral mucositis incidence of 65.2% and severe (grade 3/4) mucositis in 28.0%, and they describe the treatment as appearing effective, though the single-arm design lacks a control group.
- Participants
- 118
- Who or what was studied
- Patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy at multiple cancer centers in Brazil
- Limits stated in the abstract
- The single-arm observational design has no control group, so the effect of photobiomodulation cannot be established from these data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Observational study, Oral mucositis, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.